Skip to main content

Table 1 Reported outcomes

From: Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Studies

Reported outcomes

Follow up period

Types of patients

Gorst 2016 [8]

Stroke/SE/TIA, any bleeding, death, intracranial bleeding, GI bleeding, venous thromboembolism

1 year

-

Larock 2014 [9]

Stroke/TIA, venous thromboembolism, any bleeding, death

-

NVAF

Maura 2015 [10]

Bleeding events, ischemic stroke/SE

3 months

NVAF

Providencia 2014 [11]

Death, thromboembolism, stroke, TIA, SE, major bleeding, minor bleeding

30 days

-

Sherid 2014 [12]

Major bleeding other than GI bleeding, intracranial hemorrhage, stroke/TIA, venous thromboembolism, death, GI bleeding

40 days

-

  1. Abbreviations: SE systemic embolism, TIA transient ischemic attack, GI gastrointestinal, NVAF non-valvular atrial fibrillation